ClinicalTrials.gg
Drug

Linerixibat clinical trials

Also written GSK2330672.

studies test it
14
open now
1
in phase 3
3
first study started
2011

How each study uses linerixibat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the linerixibat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 Mar 2026 · LYNAVOY · NDA 220295 (FDA, Drugs@FDA)
European Union
22 Oct 2026 · Lynavoy · EMEA/H/C/006241 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Linerixibat
6

Development codes

GSK2330672
5

Studies by the year they started

14 studies that test it; most in 2014 (2)

Studies that test linerixibat, by start year
YearStudies
20111
20121
20131
20142
20171
20192
20201
20212
20222
20261

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
4
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 0

GlaxoSmithKline (14)

Often tested with

Tested in the same studies.

Obeticholic acid (2)

Studies

Open first, then newest update. How each study uses linerixibat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14

Codes

What other systems call linerixibat · ClinicalTrials.gg INT002192

  • MeSH (NLM) C000732018linerixibatOne source NLM
  • UNII (FDA) 386012Z45SLINERIXIBATConfirmed FDA, NLM, Wikidata
  • Wikidata Q27256749linerixibatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166652LinerixibatOne source FDA
  • DrugBank DB11729One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.